Stephen R. Bloom
Sir Stephen Bloom | |
|---|---|
 Bloom in 2013 | |
| Born | Stephen Robert Bloom 24 October 1942[2] |
| Alma mater | University of Cambridge (MA, MD) |
| Spouse |
Margaret Janet Bloom (née Sturrock)
(m. 1965) |
| Children | four[2] |
| Awards | |
| Scientific career | |
| Institutions | |
Sir Stephen Robert Bloom FRS[1] (born 24 October 1942) is a British Professor of Medicine at Imperial College London where he leads the Diabetes, Endocrinology and Metabolism division.[4][5][6][7][8]
Education
Bloom was educated at
specialist registrar at Middlesex Hospital, University College London, where he also received his Medical Research Council (MRC)
Clinical Research Fellowship training.
Awards and honours
Bloom was elected a
National Institute for Health Research (NIHR).[10]
Bloom was also
Academy of Medical Sciences (FMedSci) and the Royal Society of Biology
(FRSB). Bloom is Chairman of a Biotechnology Company, Zihipp, which completed round A funding in January 2020. It specialises in peptide hormone analogues to treat obesity and diabetes.
References
- ^ a b c "Professor Stephen Bloom FRS". London: The Royal Society. Archived from the original on 5 August 2014.
- ^ a b c "Bloom, Prof. Sir Stephen (Robert)". Who's Who. Vol. 2015 (online Oxford University Press ed.). A & C Black. (Subscription or UK public library membership required.)
- ^ "Bloom, Margaret Janet, (Lady Bloom)". Who's Who. Vol. 2015 (online Oxford University Press ed.). A & C Black. (Subscription or UK public library membership required.)
- ^ Stephen R. Bloom's publications indexed by the Scopus bibliographic database. (subscription required)
- S2CID 4300829.
- S2CID 4431600.
- S2CID 11764433.
- ^ "Professor Sir Stephen Bloom, FRS". Imperial College London. Archived from the original on 18 November 2014.
- ^ "UK Government Grants awarded to Stephen R. Bloom". Research Councils UK. Retrieved 5 January 2022.
- PMID 24381724.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
